Company profile: Allurion
1.1 - Company Overview
Company description
- Provider of a non-surgical weight-loss solution featuring the Allurion Balloon, a swallowable gastric capsule placed and removed without surgery, endoscopy, or anesthesia. Provides the 6-month Allurion Programme with medical support, digital tools (Connected Scale, App), and nutritional coaching, plus the Allurion Virtual Care Suite for remote monitoring, telehealth, and collaboration.
Products and services
- Allurion Programme: A 6-month integrated weight-loss program combining the Allurion Balloon, clinician oversight, Allurion Connected Scale, Allurion App, and nutritional coaching to orchestrate remote tracking and structured behavioral support
- Allurion Balloon: A non-invasive gastric balloon swallowed as a capsule, requiring no surgery, endoscopy, or anesthesia, engineered to reside in the stomach for approximately 16 weeks to facilitate weight reduction
- Allurion Virtual Care Suite: A remote-monitoring digital platform for patient management, offering telehealth and collaboration tools to support continuous engagement and clinician coordination throughout the Allurion Programme
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Allurion
Metsera
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies and health technology tools for obesity and metabolic diseases, developing next-generation oral and injectable treatments using a proprietary peptide and monoclonal antibody library; includes MET-097, a potential once-monthly injectable GLP-1 receptor agonist, and tools for personalization and risk prediction in weight management and obesity-related conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metsera company profile →
Versanis Bio
HQ: United States
Website
- Description: Provider of medicines addressing medical conditions prevalent in older adults, discovering and developing therapies including bimagrumab, a human monoclonal antibody to activin type II receptors that blocks binding of ligands including activin A and myostatin; bimagrumab has been studied by Novartis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Versanis Bio company profile →
CoolSculpting
HQ: United States
Website
- Description: Provider of non-invasive body contouring medical devices and treatments, including CoolSculpting, which uses cryolipolysis to freeze and eliminate fat cells in targeted areas; CoolTone, which employs Active Magnetic Pulse (AMP) technology to induce muscle contractions to strengthen and tone the abdomen, glutes, and thighs; and CoolSculpting Elite, enabling dual applicator treatment of two areas simultaneously.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoolSculpting company profile →
Apollo Endosurgery
HQ: United States
Website
- Description: Provider of device-based therapies for diagnosis and treatment of gastrointestinal diseases that offer less invasive alternatives to surgery, aiming to lower complication rates and healthcare costs. Products include the Apollo ESG and Revise systems for obesity, Orbera intragastric balloon, OverStitch endoscopic suturing system, and X-Tack endoscopic HeliX tacking system for suture-based closure of large or irregular defects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apollo Endosurgery company profile →
GT Metabolic Solutions
HQ: United States
Website
- Description: Provider of minimally-invasive incision-less bypass technology for bariatric, metabolic, and digestive surgery, offering a gastrointestinal device system for performing side-to-side gastrointestinal magnetic compression anastomosis and the 2nd Annual International Symposium on Magnetic Gastro-Intestinal & Colon Surgery, an event focused on magnetic gastrointestinal and colon surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GT Metabolic Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Allurion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Allurion
2.2 - Growth funds investing in similar companies to Allurion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Allurion
4.2 - Public trading comparable groups for Allurion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →